跳至主要内容
临床试验/NCT01087619
NCT01087619进行中(未招募)不适用

Primary Hyperparathyroidism in Patients Older Than 65 Years: A Prospective Randomized Trial of Surgical Treatment Compared With Follow-up

Region Skane1 个研究点 分布在 1 个国家目标入组 115 人开始时间: 2010年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
Region Skane
入组人数
115
试验地点
1
主要终点
Bone density at the hip

研究概览

简要总结

General consensus and contemporary guidelines, recommend surgery for primary hyperparathyroidism (pHPT)for all patients below the age of 50, for patients with pronounced hypercalcemia and for patients with organ complications to the disease (osteoporosis and decreased renal function).

The purpose of this study is to determine if surgery for pHPT, is appropriate for patients with moderate to mild hypercalcemia older than 65 years of age.

The hypothesis of the study is that surgery for pHPT in patients older than 65 years of age, and with mild hypercalcemia, will increase bone density and hence decrease future risk for fragility fractures compared to patients with follow-up only.

详细描述

The majority of patients diagnosed and operated due to primary HPT in Scandinavia are older than 65 years of age. The vast majority of the patients have mild aberrations of serum calcium (< 1.50 mmol/l ionized calcium), and some patients may even be asymptomatic. The present trial is designed to clarify the indications for surgical treatment in this large subgroup of patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
66 Years 至 —(Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Primary Hyperparathyroidism
  • •No previous parathyroid surgery
  • •Sporadic disease

排除标准

  • •Z-score of Bone density < -2.5 SD (regardless of site)
  • •Serum level of ionized calcium > 1.50 mmol/L
  • •Inability to understand given information or to comply with scheduled follow-up
  • •Symptoms of hypercalcaemia for which specific medical treatment has been prescribed

研究组 & 干预措施

Follow-up

No Intervention

Patients diagnosed biochemically and clinically with primary hyperparathyroidism who are followed only

Surgery

Experimental

Patients diagnosed biochemically and clinically with primary hyperparathyroidism who are treated with parathyroid surgery

干预措施: Parathyroid surgery (Procedure)

结局指标

主要结局

Bone density at the hip

时间窗: At two years

Bone density is assessed with DEXA (dual energy x-ray absorptiometry), at the hip.

次要结局

  • Cardiac function(At two years)
  • Blood lipids(At two years)
  • Blood pressure (systolic and diastolic)(At two years)
  • Atherosclerosis(At one two years)
  • Renal function(At two years)
  • Bone density at the lumbar spine(At two years)
  • Cognitive function(At two years)
  • Oral glucose tolerance(At two years)

研究者

发起方
Region Skane
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

撤回
不适用
Surgical Approach for Primary Hyperparathyroidism in the ElderlyMultigland Disease in Primary Hyperparathyroidism
NCT01484379Rambam Health Care Campus
进行中(未招募)
1 期
Primary hyperparathyroidism: does a systematic treatment improve the calcium and bone metabolism after successful surgery? – Part IISystematic treatment of patients with neither osteopenia nor osteoporosis after successful surgical treatment for primary hyperparathyroidism with Calcium and Vitamin DHypothesis: Calcium and vitamin D intake after surgery for PHPT protects the bone by keeping PTH in the normal range (less secondary, reactive hyperparathyroidism), prevents hungry bone- syndrome and improve bone-turnover markers (osteoporosis protection).MedDRA version: 9.1Level: LLTClassification code 10020707Term: Hyperparathyroidism primary
EUCTR2008-001704-23-ATMedizinische Universität Wien, Universitätsklinik für Chirurgie80
进行中(未招募)
1 期
Primary hyperparathyroidism: does a systematic treatment improve the calcium- and bone metabolism after successful surgery? – Part Systematic treatment of osteopenic and osteoporotic postmenopausal patients after successful surgical treatment for primary hyperparathyroidism with Strontium ranelateOsteopenia or Osteoporosis in postmenopausal womenPrimary hyperparathyroidismMedDRA version: 9.1Level: LLTClassification code 10020707Term: Hyperparathyroidism primaryMedDRA version: 9.1Level: PTClassification code 10031285Term: Osteoporosis postmenopausal
EUCTR2008-001703-32-ATMedical University of Vienna60
招募中
不适用
Cohort Primary HyperparathyroidismPrimary Hyperparathyroidism
NCT05469087Nantes University Hospital403
已完成
不适用
A Retrospective Analysis of the Diagnostic Performance of 11C-choline PET/CT in Primary HyperparathyroidismPrimary Hyperparathyroidism Due to AdenomaPrimary Hyperparathyroidism
NCT04608253University Medical Center Groningen36